Correlation between gene mutation status and molecular subtypes
Prostate Adenocarcinoma (Primary solid tumor)
22 February 2013  |  analyses__2013_02_22
Maintainer Information
Citation Information
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2013): Correlation between gene mutation status and molecular subtypes. Broad Institute of MIT and Harvard. doi:10.7908/C12B8W72
Overview
Introduction

This pipeline computes the correlation between significantly recurrent gene mutations and molecular subtypes.

Summary

Testing the association between mutation status of 13 genes and 6 molecular subtypes across 83 patients, one significant finding detected with P value < 0.05 and Q value < 0.25.

  • SPOP mutation correlated to 'CN_CNMF'.

Results
Overview of the results

Table 1.  Get Full Table Overview of the association between mutation status of 13 genes and 6 molecular subtypes. Shown in the table are P values (Q values). Thresholded by P value < 0.05 and Q value < 0.25, one significant finding detected.

Clinical
Features
CN
CNMF
METHLYATION
CNMF
MRNASEQ
CNMF
MRNASEQ
CHIERARCHICAL
MIRSEQ
CNMF
MIRSEQ
CHIERARCHICAL
nMutated (%) nWild-Type Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test
SPOP 4 (5%) 79 0.00264
(0.195)
0.0499
(1.00)
0.1
(1.00)
0.226
(1.00)
0.565
(1.00)
1
(1.00)
NKX3-1 5 (6%) 78 0.351
(1.00)
0.248
(1.00)
0.546
(1.00)
0.166
(1.00)
0.118
(1.00)
0.14
(1.00)
TP53 5 (6%) 78 0.00525
(0.383)
0.248
(1.00)
0.376
(1.00)
0.121
(1.00)
0.494
(1.00)
1
(1.00)
FRG1 4 (5%) 79 0.262
(1.00)
0.2
(1.00)
0.494
(1.00)
0.781
(1.00)
0.565
(1.00)
1
(1.00)
YBX1 3 (4%) 80 0.709
(1.00)
0.0945
(1.00)
0.277
(1.00)
0.252
(1.00)
1
(1.00)
0.594
(1.00)
CCNF 3 (4%) 80 1
(1.00)
0.791
(1.00)
0.773
(1.00)
1
(1.00)
1
(1.00)
1
(1.00)
CLSTN1 3 (4%) 80 1
(1.00)
0.457
(1.00)
0.494
(1.00)
0.781
(1.00)
0.707
(1.00)
0.325
(1.00)
PRR21 4 (5%) 79 0.709
(1.00)
0.353
(1.00)
0.494
(1.00)
0.178
(1.00)
0.194
(1.00)
1
(1.00)
AGT 3 (4%) 80 0.709
(1.00)
1
(1.00)
1
(1.00)
1
(1.00)
1
(1.00)
0.16
(1.00)
CTNNB1 3 (4%) 80 1
(1.00)
0.602
(1.00)
0.773
(1.00)
0.343
(1.00)
0.322
(1.00)
0.325
(1.00)
DUSP27 3 (4%) 80 0.544
(1.00)
0.457
(1.00)
0.707
(1.00)
0.325
(1.00)
OR4D5 3 (4%) 80 0.239
(1.00)
1
(1.00)
0.707
(1.00)
1
(1.00)
OR6N1 3 (4%) 80 0.384
(1.00)
1
(1.00)
1
(1.00)
0.465
(1.00)
0.0778
(1.00)
0.594
(1.00)
'SPOP MUTATION STATUS' versus 'CN_CNMF'

P value = 0.00264 (Fisher's exact test), Q value = 0.2

Table S1.  Gene #4: 'SPOP MUTATION STATUS' versus Clinical Feature #1: 'CN_CNMF'

nPatients CLUS_1 CLUS_2 CLUS_3
ALL 11 45 26
SPOP MUTATED 3 0 1
SPOP WILD-TYPE 8 45 25

Figure S1.  Get High-res Image Gene #4: 'SPOP MUTATION STATUS' versus Clinical Feature #1: 'CN_CNMF'

Methods & Data
Input
  • Mutation data file = PRAD-TP.mutsig.cluster.txt

  • Molecular subtypes file = PRAD-TP.transferedmergedcluster.txt

  • Number of patients = 83

  • Number of significantly mutated genes = 13

  • Number of Molecular subtypes = 6

  • Exclude genes that fewer than K tumors have mutations, K = 3

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[1] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[2] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)